Oncology News

Results from patients enrolled in a phase I study and FDA expanded access programme presented at AACR 2019

Extended indication concerns treatment of male patients

Results from meta analysis of foecal metagenomes

New indication concern combination with G-CSF to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours

Change in one of the existing indications concerns combination therapy in adult patients with previously untreated multiple myeloma who are not eligible for transplant 

New indication concerns treatment of adult patients with multiple myeloma in combination with bortezomib and dexamethasone after at least one prior regimen including lenalidomide

EMA published questions-and-answers document for patients, healthcare professionals and the general public

Insights from the patient-derived xenograft models of breast cancer in mice

Pertuzumab, with intravenous trastuzumab and chemotherapy, is recommended for the adjuvant treatment of HER2-positive early stage breast cancer in adults at high risk of recurrence

It is recommended in patients with ALK-positive advanced NSCLC who have already had crizotinib

EMA will assess available data in relation to existing screening methods to detect DPD deficiency

Approval is based on results from the IMpower133 study